In our study, no negative association between apoC1 concentration and CETP activity was observed in people with T1D after improvement of glycemic control, suggesting that hyperglycemia does not seem to be a critical factor in vivo, explaining the loss of the capacity of apoC1 to inhibit CETP activity in people with T1D. The gene discussed is APOC1; the disease is Hyperglycemia.